Subjective Effects of Cannabis Before the First Psychotic Episode
Bart D. Peters, Pelle de Koning, Peter M. A. J. Dingemans, Hiske E. Becker, Don H. Linszen, Lieuwe de Haan
Australian & New Zealand Journal of Psychiatry December 1, 2009 DOI: 10.3109/00048670903179095 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional questionnaire study Longitudinal Qualitative Peer reviewed |
|---|---|
| Sample size | 121 |
| Population | Male subjects with recent-onset schizophrenia or related disorder (n=52), help-seeking male subjects at ultra-high risk for psychosis (n=17), and cannabis-using male controls from the general population (n=52) |
| Intervention | Cannabis |
| Topics | Cannabis |
| Citations | 35 |
| Key findings | Recent-onset schizophrenia patients and ultra-high-risk subjects reported more negative subjective effects of cannabis than general-population users, including anxiety, depression, suspiciousness, hallucinations, and confusion; 37% of recent-onset patients reported their first psychotic symptoms occurred during cannabis intoxication. The authors conclude that these groups may be more sensitive to psychotic effects of cannabis and that cannabis may be a component cause in the onset of the first psychotic episode. |
Abstract
Objective: The aim of the present study was to gain more insight into the positive and negative effects of cannabis in the prodromal phase of schizophrenia and in the ultra-high-risk (UHR) state for psychosis.
Method: A theory-driven questionnaire was used to examine subjective effects in the prodromal phase in male subjects with a recent onset of schizophrenia or related disorder (n = 52) and in the UHR state in help-seeking male subjects screened for being at UHR for psychosis (n = 17); both groups were compared to cannabis-using controls from the general population (n=52).
Results: Recent-onset patients and UHR subjects reported feeling more anxious, depressed and suspicious immediately after cannabis use. Some patients also reported feeling less depressed after cannabis use. Recent-onset patients reported increased visual and acoustic hallucinations, and confusion after cannabis use. Of the recent-onset patients 37% reported that their very first psychotic symptoms occurred during cannabis intoxication. Long-term effects of cannabis reported more often by both patient groups were depression, less control over thoughts and social problems.
Conclusions: These results suggest that schizophrenia patients in the prodromal phase and subjects at UHR for psychosis are more sensitive to some negative effects of cannabis, in particular psychotic effects, compared to cannabis users from the general population. Although limited by the retrospective design in the recent-onset patients, the present study adds qualitative evidence to longitudinal studies that suggest that cannabis is a component cause in the onset of the first psychotic episode. Further studies are needed on the objective and subjective effects of cannabis in UHR subjects.
Comparable studies
Other cross-sectional and survey studies on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Cannabis use before age 15 and subsequent executive functioning 104 chronic cannabis users (49 early-onset before age 15, 55 late-onset after age 15)... | 2011 | Observational cross-sectional study | n = 148 |
| Patterns of simultaneous polysubstance use in drug using university students Drug-using university students | 2006 | Cross-sectional survey | n = 149 |
| Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Online survey respondents | 2020 | Cross-sectional survey | |
| User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire | 2010 | Cross-sectional survey | n = 600 |
| Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner Adults recruited from the MAPS website and newsletter, most reporting use of various... | 2012 | Cross-sectional survey | n = 337 |
Citations in the library
Cited by 8
- Gone to Pot – A Review of the Association between Cannabis and Psychosis Frontiers in Psychiatry May 22, 2014
- Cannabis use and cognitive dysfunction Indian Journal of Psychiatry 2011
- Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers Psychological Medicine October 1, 2012
- Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis Translational Psychiatry September 6, 2022
- Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool. Psychological Medicine 2024
and 3 more in the library
Cites 5
- Cannabis and psychosis: an update on course and biological plausible mechanisms. Current Opinion in Psychiatry March 2007
- Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry March 15, 2005
- Reasons for cannabis use in men with and without psychosis Drug and Alcohol Review December 1, 2004
- Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats. Synapse July 2003
- Repeated exposure to Δ9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat April 10, 1998